Werewolf Therapeutics, Inc. financial data

Symbol
HOWL on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Talcott Avenue, 2 Nd Floor, Watertown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 840 % +24.9%
Debt-to-equity 53.2 % +19.3%
Return On Equity -48.3 % -45.2%
Return On Assets -31.5 % -37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.7M shares +22.6%
Common Stock, Shares, Outstanding 43.7M shares +22.6%
Entity Public Float 67.4M USD +13.6%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 43.5M shares +22.4%
Weighted Average Number of Shares Outstanding, Diluted 44M shares +23.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 48.7M USD -3.09%
General and Administrative Expense 19M USD +1.96%
Operating Income (Loss) -58.3M USD -32.6%
Nonoperating Income (Expense) 4.61M USD +50.7%
Net Income (Loss) Attributable to Parent -53.7M USD -31.2%
Earnings Per Share, Basic -1.36 USD/shares -8.8%
Earnings Per Share, Diluted -1.39 USD/shares -11.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 135M USD -1.56%
Assets, Current 139M USD -5.84%
Property, Plant and Equipment, Net 7.09M USD -15.4%
Operating Lease, Right-of-Use Asset 6.35M USD -18.5%
Other Assets, Noncurrent 265K USD -59.4%
Assets 154M USD -17%
Accounts Payable, Current 1.47M USD -1.54%
Employee-related Liabilities, Current 2.27M USD +2.34%
Accrued Liabilities, Current 8.7M USD -12.5%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 11.4M USD -23.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 10.2M USD -12.5%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 49.7M USD -25.4%
Retained Earnings (Accumulated Deficit) -378M USD -16.6%
Stockholders' Equity Attributable to Parent 104M USD -12.3%
Liabilities and Equity 154M USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.3M USD -54.5%
Net Cash Provided by (Used in) Financing Activities 20.3M USD -58.3%
Net Cash Provided by (Used in) Investing Activities -111K USD +33.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 43.7M shares +22.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.85M USD -87.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 137M USD -14%
Interest Paid, Excluding Capitalized Interest, Operating Activities 910K USD
Deferred Tax Assets, Valuation Allowance 47.1M USD +10.9%
Deferred Tax Assets, Gross 50.3M USD +8.77%
Operating Lease, Liability 12.6M USD -14.2%
Depreciation 464K USD +9.18%
Payments to Acquire Property, Plant, and Equipment 111K USD -33.9%
Lessee, Operating Lease, Liability, to be Paid 16M USD -16.4%
Property, Plant and Equipment, Gross 11.1M USD +7.06%
Operating Lease, Liability, Current 1.27M USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.34M USD -6.71%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.51M USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.37M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.4M USD +2.82%
Deferred Tax Assets, Operating Loss Carryforwards 23.9M USD -9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.47M USD +2.83%
Additional Paid in Capital 482M USD +8.85%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.2M USD -15.6%
Share-based Payment Arrangement, Expense 8.88M USD +12.1%
Interest Expense 1M USD +483%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%